1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA02714282
BREMNER CAPITAL MANAGEMENT Company Update Effie Tsotsani Tekmira Pharmaceuticals (TKMR US) — Investment Stance: Positive PT C$67 March 2014 Company overview: Tekmira Pharmaceuticals is a leading RNA interference (RNAi) Therapeu
No connected entities